Focal Gains of <i>VEGFA</i> and Molecular Classification of Hepatocellular Carcinoma
Derek Y. Chiang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Azra H. Ligon(Brigham and Women's Hospital), Clara Alsinet(Hospital Clínic de Barcelona), Vesna Najfeld, Beatriz Mínguez, Judit Peix, Jordi Barretina(Broad Institute), Victoria Tovar(Hospital Clínic de Barcelona), Matthew Meyerson(Broad Institute), William R. Sellers(Broad Institute), Augusto Villanueva(NYU Langone Health), Diana Donovan(Brigham and Women's Hospital), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Alex H. Ramos(Broad Institute), Manel Solé(Hospital Clínic de Barcelona), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Philippa Newell, Jordi Bruix(Hospital Clínic de Barcelona), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Samuel Waxman(Icahn School of Medicine at Mount Sinai), Amanda C. LeBlanc, Sasan Roayaie(Icahn School of Medicine at Mount Sinai), Yujin Hoshida(Broad Institute)
Cited by 712
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Management of Hepatocellular Carcinoma: An Update Δσ
|Hepatology|2011|8.1k
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Management of Hepatocellular Carcinoma *
|Hepatology|2005|5.9k